Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

96 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines.
Cottu PH, Muzeau F, Estreicher A, Fléjou JF, Iggo R, Thomas G, Hamelin R. Cottu PH, et al. Among authors: iggo r. Oncogene. 1996 Dec 19;13(12):2727-30. Oncogene. 1996. PMID: 9000147
Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.
Tada M, Iggo RD, Ishii N, Shinohe Y, Sakuma S, Estreicher A, Sawamura Y, Abe H. Tada M, et al. Among authors: iggo rd. Int J Cancer. 1996 Jul 29;67(3):447-50. doi: 10.1002/(SICI)1097-0215(19960729)67:3<447::AID-IJC22>3.0.CO;2-3. Int J Cancer. 1996. PMID: 8707423
Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast.
Flaman JM, Robert V, Lenglet S, Moreau V, Iggo R, Frebourg T. Flaman JM, et al. Among authors: iggo r. Oncogene. 1998 Mar 12;16(10):1369-72. doi: 10.1038/sj.onc.1201889. Oncogene. 1998. PMID: 9546439
A rapid PCR fidelity assay.
Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Ishioka C, Friend SH, Iggo R. Flaman JM, et al. Among authors: iggo r. Nucleic Acids Res. 1994 Aug 11;22(15):3259-60. doi: 10.1093/nar/22.15.3259. Nucleic Acids Res. 1994. PMID: 8065949 Free PMC article. No abstract available.
The human tumour suppressor gene p53 is alternatively spliced in normal cells.
Flaman JM, Waridel F, Estreicher A, Vannier A, Limacher JM, Gilbert D, Iggo R, Frebourg T. Flaman JM, et al. Among authors: iggo r. Oncogene. 1996 Feb 15;12(4):813-8. Oncogene. 1996. PMID: 8632903
Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology.
Inga A, Iannone R, Monti P, Molina F, Bolognesi M, Abbondandolo A, Iggo R, Fronza G. Inga A, et al. Among authors: iggo r. Oncogene. 1997 Mar 20;14(11):1307-13. doi: 10.1038/sj.onc.1200952. Oncogene. 1997. PMID: 9178891
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R, Fronza G. Campomenosi P, et al. Among authors: iggo r. Oncogene. 2001 Jun 14;20(27):3573-9. doi: 10.1038/sj.onc.1204468. Oncogene. 2001. PMID: 11429705
Evaluation of methods to detect p53 mutations in ovarian cancer.
Meinhold-Heerlein I, Ninci E, Ikenberg H, Brandstetter T, Ihling C, Schwenk I, Straub A, Schmitt B, Bettendorf H, Iggo R, Bauknecht T. Meinhold-Heerlein I, et al. Among authors: iggo r. Oncology. 2001;60(2):176-88. doi: 10.1159/000055316. Oncology. 2001. PMID: 11244334
Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma.
Fujimoto H, Sasaki J, Matsumoto M, Suga M, Ando Y, Iggo R, Tada M, Saya H, Ando M. Fujimoto H, et al. Among authors: iggo r. Jpn J Cancer Res. 1998 Jul;89(7):696-702. doi: 10.1111/j.1349-7006.1998.tb03273.x. Jpn J Cancer Res. 1998. PMID: 9738975 Free PMC article.
Prognostic significance of p53 mutation in breast cancer: frequent detection of non-missense mutations by yeast functional assay.
Chappuis PO, Estreicher A, Dieterich B, Bonnefoi H, Otter M, Sappino AP, Iggo R. Chappuis PO, et al. Among authors: iggo r. Int J Cancer. 1999 Dec 22;84(6):587-93. doi: 10.1002/(sici)1097-0215(19991222)84:6<587::aid-ijc8>;2-8. Int J Cancer. 1999. PMID: 10567903
96 results
Jump to page